Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dai Maruyama

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 15, 2020
[Ⅳ.B-Cell Maturation Antigen(BCMA)-Targeting Therapy in Multiple Myeloma]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 8, 2011
[Novel monoclonal antibodies for the treatment of malignant lymphomas]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 10, 2021
[Overview]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2011
[Treatment of Burkitt lymphoma and Burkitt-like lymphoma]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 2, 2024
[Current standard treatments and future outlook for follicular lymphoma]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Malignant lymphoma in adolescents and young adults: from the viewpoint of physiciansDai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 13, 2016
Immune-checkpoint inhibitors in hematologic malignanciesDai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Treatment strategy of gray zone lymphomas]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 10, 2020
[Brentuximab vedotin and immune checkpoint inhibitors for the treatment of Hodgkin lymphoma]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Treatment strategy for high-grade B-cell lymphoma]Dai Maruyama
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 15, 2020
[Ⅳ.B-Cell Maturation Antigen(BCMA)-Targeting Therapy in Multiple Myeloma]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 8, 2011
[Novel monoclonal antibodies for the treatment of malignant lymphomas]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 10, 2021
[Overview]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2011
[Treatment of Burkitt lymphoma and Burkitt-like lymphoma]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 2, 2024
[Current standard treatments and future outlook for follicular lymphoma]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Malignant lymphoma in adolescents and young adults: from the viewpoint of physiciansDai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 13, 2016
Immune-checkpoint inhibitors in hematologic malignanciesDai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Treatment strategy of gray zone lymphomas]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 10, 2020
[Brentuximab vedotin and immune checkpoint inhibitors for the treatment of Hodgkin lymphoma]Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Treatment strategy for high-grade B-cell lymphoma]Dai Maruyama
Pageof 22